当前位置:
X-MOL 学术
›
Eur. Heart J. Cardiovasc. Pharmacother.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
FLOW trial stopped early due to evidence of renal protection with semaglutide.
European Heart Journal-Cardiovascular Pharmacotherapy ( IF 7.1 ) Pub Date : 2023-11-02 , DOI: 10.1093/ehjcvp/pvad080 Felice Gragnano 1, 2 , Vincenzo De Sio 1, 2 , Paolo Calabrò 1, 2
中文翻译:
由于索马鲁肽具有肾脏保护作用的证据,FLOW 试验提前停止。
更新日期:2023-11-02
European Heart Journal-Cardiovascular Pharmacotherapy ( IF 7.1 ) Pub Date : 2023-11-02 , DOI: 10.1093/ehjcvp/pvad080 Felice Gragnano 1, 2 , Vincenzo De Sio 1, 2 , Paolo Calabrò 1, 2
Affiliation
中文翻译:
由于索马鲁肽具有肾脏保护作用的证据,FLOW 试验提前停止。